Brighton Jones’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
ACM
Brighton Jones's LRMR Position: Q3 2026 in Review
Brighton Jones reduced its Larimar Therapeutics (LRMR) stake by 41% in Q3 2026, selling an estimated $29.6K and leaving 10,822 shares worth $34.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1366.
Brighton Jones first reported a position in LRMR in Q2 2026 and has held it in 2 quarters since. The position peaked at $56.4K in Q2 2026. 113 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.
- Brighton Jones held 10,822 shares of Larimar Therapeutics worth $34.6K as of Q3 2026.
- Brighton Jones sold 7,654 Larimar Therapeutics shares in Q3 2026, an estimated $29.6K.
- Larimar Therapeutics made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1366 holding.
- Brighton Jones first reported a position in Larimar Therapeutics in Q2 2026 and has held it in 2 quarters since.
- Brighton Jones's Larimar Therapeutics position peaked at $56.4K in Q2 2026.
- 113 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.